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Summary statement 
 
Zebrafish inflammation screen identifies a new series of structurally related 
compounds with combined anti-inflammatory and pro-resolution activity, and reveals 
a previously unknown mechanism of action of clinical cromones.  
 
 
Abstract 
 
Neutrophils are essential for host defence and are recruited to sites of inflammation 
in response to tissue injury or infection. For inflammation to resolve, these cells must 
be cleared efficiently and in a controlled manner, either by apoptosis or reverse 
migration. If the inflammatory response is not well regulated, persistent neutrophils 
may cause damage to host tissues and contribute to the pathogenesis of chronic 
inflammatory diseases, which respond poorly to current treatments. It is therefore 
important to develop drug discovery strategies that can identify new therapeutics 
specifically targeting neutrophils, either by promoting their clearance or by preventing 
their recruitment. Our recent in vivo chemical genetic screen for accelerators of 
inflammation resolution identified a subset of compounds sharing a common 
chemical signature, the bicyclic benzopyrone rings. Here, we further investigate the 
mechanisms of action of the most active of this chemical series, isopimpinellin, in our 
zebrafish model of neutrophilic inflammation. We found that this compound targets 
both the recruitment and resolution phases of the inflammatory response. Neutrophil 
migration towards a site of injury is reduced by isopimpinellin and this occurs as a 
result of PI3K inhibition. We also show that isopimpinellin induces neutrophil 
apoptosis to drive inflammation resolution in vivo using a new zebrafish reporter line 
detecting in vivo neutrophil caspase-3 activity and allowing quantification of flux 
through the apoptotic pathway in real-time. Finally, our studies reveal that clinically 
available ‘cromones' are structurally related to isopimpinellin and have previously 
undescribed pro-resolution activity in vivo. These findings may have implications for 
the therapeutic use of benzopyrones in inflammatory disease. 
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Introduction 
 
The acute inflammatory response is an essential host defence mechanism and is 
initiated by the innate immune system in the event of tissue injury or infection. It is a 
highly controlled sequence of events that involves the coordinated activity of multiple 
cytokines, lipid mediators and cell types, and can be broadly split into 3 phases: 
recruitment, peak inflammation and resolution (Serhan et al., 2007). One of the most 
important innate immune cells involved in the inflammatory response is the 
neutrophil. During the recruitment phase, these cells are activated in response to 
inflammatory stimuli and migrate to inflamed tissue, following gradients of soluble 
chemokines such as interleukin-8 (IL-8 or CXCL8) (Medzhitov, 2008). This 
chemokine signals via CXCR2 receptors on the neutrophil surface to activate 
downstream pathways, including the phosphatidylinositol 3-kinase (PI3K) pathway 
that is required for neutrophil chemotaxis (Ferguson et al., 2007; Hirsch et al., 2000; 
Yoo et al., 2010). Once at the site of inflammation, neutrophils eliminate any invading 
pathogens by phagocytosis, degranulation and the production of reactive oxygen 
species and extracellular traps (Fox et al., 2010). Inflammation must then resolve in 
order to restore homeostasis and promote tissue repair. During the resolution phase, 
neutrophils are removed either by undergoing apoptosis and engulfment by 
macrophages, or by leaving the site of inflammation by reverse migration (Henry et 
al., 2013). 
 
If inflammation is not well regulated, persistent neutrophilic inflammation may cause 
host tissue damage and chronic inflammation, which can contribute to the 
pathogenesis of diseases such as chronic obstructive pulmonary disease (COPD), 
rheumatoid arthritis and atherosclerosis (Serhan et al., 2007). Many of these are 
characterised by unresolved neutrophilic inflammation and respond poorly to current 
therapies, making the neutrophil a key target for drug discovery approaches. 
Potentially, drugs used to treat inflammatory disease may act either by preventing 
the further recruitment and accumulation of neutrophils at inflammatory sites (‘anti-
inflammatory’) or by promoting neutrophil clearance to drive inflammation resolution 
(‘pro-resolution’).  
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The zebrafish (Danio rerio) is a powerful model for the study of vertebrate biology. 
The development of transgenic lines labelling innate immune cells has enabled in 
vivo investigation of the mechanisms regulating the different phases of the 
inflammatory response (Ellett et al., 2010; Hall et al., 2007; Mathias et al., 2006; 
Renshaw et al., 2006). With its transparent larvae, small size and high fecundity, the 
zebrafish model lends itself particularly well to drug discovery by high-throughput 
chemical genetic screening, and multiple success stories are emerging using this 
unique whole-organism approach (Hall et al., 2014; North et al., 2007; Takaki et al., 
2012; Tamplin et al., 2014; Wang et al., 2013). 
 
We recently described a chemical genetic screen for accelerators of inflammation 
resolution, in which we found the first compound that could promote neutrophil 
reverse migration to drive inflammation resolution in vivo (Robertson et al., 2014). 
Here, we investigate the mechanism of action of the largest described, structurally 
distinct subset of active compounds from an in vivo chemical genetic anti-
inflammatory screen. These compounds share both structural and functional 
similarity and their activity is two-fold: neutrophil recruitment is inhibited and 
inflammation resolution is accelerated. We also describe a new zebrafish reporter 
line for in vivo neutrophil caspase-3 activity, which allows us to visualise neutrophil 
apoptosis during inflammation resolution in real-time. Finally, our studies led to the 
discovery of a previously undescribed mechanism of action for a group of clinically 
available therapeutics, the cromones, which may impact on their use in inflammatory 
disease. 
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Results 
 
Zebrafish inflammation drug screen identifies a chemical series with structural and 
functional similarity 
We recently established a drug screening assay in a transgenic zebrafish model of 
acute inflammation and identified 21 new pro-resolution compounds (Robertson et 
al., 2014). Structural similarity comparisons revealed that a particular chemical 
group, consisting of fused benzene and pyran rings with an attached carbonyl group, 
was common to a subset of these. Commonly referred to as ‘chromone’ (1,4-
benzopyrone), this group or its isomer ‘coumarin’ (1-benzopyran-2-one) is present in 
4 of the 9 most active pro-resolution compounds identified in our screen (Fig. 1A). All 
4 of these significantly accelerated inflammation resolution in our zebrafish tail fin 
injury model and 3 of them also inhibited neutrophil recruitment (Robertson et al., 
2014). To further investigate the functionality of benzopyrone derivatives, we tested 
a further 10 commercially available related compounds and also synthesised a 
series of 5 analogue compounds for testing in our zebrafish inflammation resolution 
assay. Larvae were treated with compounds once inflammation was already 
established at 6 hours post injury (hpi) and their effects on neutrophil number were 
assessed at 12 hpi. All of the commercially available compounds significantly 
reduced neutrophil numbers at the wound (Fig. S1), along with 3 of our newly 
synthesised analogues (Fig. S2). To explore the potential significance of this 
functional group in accelerating inflammation resolution, we selected the most active 
of the benzopyrone subset identified in our screen, isopimpinellin, for mechanistic 
investigation.  
 
Isopimpinellin inhibits neutrophil recruitment in vivo 
Isopimpinellin is a naturally occurring coumarin found in plants of the Apiaceae 
family. It has been studied for its potential anti-carcinogenic properties (Kleiner et al., 
2002; Prince et al., 2006), but there is currently no published evidence to explain its 
anti-inflammatory activity. We initially investigated the effect of isopimpinellin on the 
recruitment phase of the inflammatory response in the tail fin injury assay, by treating 
zebrafish larvae immediately after wounding. At 6 hpi, we found that neutrophil 
number at the wound was reduced in isopimpinellin treated larvae compared to 
controls, in a concentration-dependent manner (Fig. 1B). When individual neutrophils 
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were tracked during the recruitment phase of inflammation, we detected a decrease 
in neutrophil speed (Fig. 1C), displacement (the linear distance each neutrophil 
travelled towards the wound) (Fig. 1D) and meandering index (the displacement 
divided by the total length of the neutrophil track) (Fig. 1E). We also found a 
difference in bearing (the angle of movement towards the wound) between the two 
groups, with fewer neutrophils moving towards the wound in the presence of 
isopimpinellin (Fig. 1F). These data suggest isopimpinellin alters the migratory 
behaviour of neutrophils, such that they move more slowly and with less 
directionality, resulting in reduced recruitment towards the chemokine gradient at the 
wound. 
 
Isopimpinellin inhibits neutrophil recruitment upstream of phosphatidylinositol 3-
kinases 
In our previous study, we compared the activity of the positive hits identified in our 
screen with a panel of compounds with known effects on inflammatory signalling 
pathways, such as inhibitors of PI3K and mitogen-activated protein kinase (MAPK), 
using hierarchical cluster analysis (Robertson et al., 2014). This indicated that the 
activity of isopimpinellin in our zebrafish inflammation assays correlated with a pan-
inhibitor of PI3K, ZSTK474. In vivo evidence suggests PI3K regulates neutrophil 
polarity and that its activation at the leading edge of cells is required for actin 
polymerisation during chemotaxis (Yoo et al., 2010). This is dependent on the tightly 
controlled spatial and temporal accumulation of phosphatidylinositol (3,4,5)-
triphosphate (PIP3), protein kinase B (Akt) and actin at the leading edge, a process 
that is impaired in neutrophils lacking PI3Kγ (Hannigan et al., 2002; Ferguson et al., 
2007). Based on the correlation between isopimpinellin and ZSTK474 revealed by 
cluster analysis, we predicted that the effect of our hit compound on neutrophil 
migration during the recruitment phase of inflammation was a result of PI3K inhibition 
and loss of the intracellular polarity required to direct migration. To investigate this, 
we used a fluorescent reporter line, which labels the pleckstrin homology domain of 
Akt with EGFP to permit visualisation of localised PI3K activity in vivo (Burgon et al., 
2014, Wang et al., 2013). In vehicle control treated larvae, the EGFP signal 
accumulated at the leading edge of neutrophils as they migrated towards the wound 
shortly after tail fin injury (Fig. 2A). In contrast, neutrophils from isopimpinellin treated 
larvae did not migrate as readily to the wound and most of these did not have a 
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defined leading edge (Fig. 2B), displaying a morphology characteristic of neutrophils 
from larvae exposed to the PI3K inhibitor LY294002 (Fig. 2C). Using a numerical 
measure of cell polarity (“polarity index”) (Wang et al., 2013), we found that 
isopimpinellin reduced neutrophil polarity to a level comparable to LY294002 (Fig. 
2D). We also examined the effect of another compound from our benzopyrone 
subset, xanthone, finding a similar reduction in neutrophil polarity (Fig. 2E). 
 
Isopimpinellin induces apoptosis of neutrophils during inflammation resolution in vivo 
We originally identified isopimpinellin as a new pro-resolution compound in our 
screen for accelerators of inflammation resolution (Robertson et al., 2014). On 
further investigation, we found that when zebrafish larvae were exposed to 
isopimpinellin once inflammation was already established at 6 hpi, there was a 
concentration-dependent reduction in neutrophil numbers at the wound at 12 hpi 
(Fig. 3A). Isopimpinellin did not affect total neutrophil number in whole larvae (Fig. 
3B). In our previous study, we showed that we could pharmacologically drive 
inflammation resolution by promoting neutrophil reverse migration (Robertson et al., 
2014). To investigate whether isopimpinellin could also act via this mechanism, we 
photoconverted neutrophils specifically at the wound region at 6 hpi in 
Tg(mpx:Gal4);Tg(UAS:Kaede)i222 larvae, as described (Elks et al., 2011; Holmes et 
al., 2012). However, we found that fewer photoconverted neutrophils migrated away 
from the wound over time in isopimpinellin treated larvae compared to the vehicle 
controls (Fig. 3C).  
 
During the course of inflammation resolution in these larvae, we often observed 
neutrophils adopting a rounded and condensed morphology, characteristic of the 
apoptotic phenotype we have previously reported (Loynes et al., 2010) (Fig. 3D). To 
further investigate neutrophil apoptosis as a pro-resolution mechanism in zebrafish, 
we developed a new Tg(mpx:FRET)sh237 reporter line by targeting a Fluorescence 
Resonance Energy Transfer (FRET)-based reporter for caspase-3 activity (Tyas et 
al., 2000) into our myeloperoxidase BAC (Renshaw et al., 2006). This FRET reporter 
consists of a CFP-YFP fluorophore pair linked by the caspase-3 cleavage sequence 
DEVD, such that when caspase-3 is activated, the linker peptide is cleaved and the 
FRET signal is lost. Neutrophil apoptosis is caspase-3 dependent (Pongracz et al., 
1999) and caspase-3 has been characterised in zebrafish, sharing 62% identity to 
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human caspase-3 and the same substrate specificities (Yabu et al., 2001). When 
imaged during the resolution phase of inflammation, we detected an increase in the 
number of apoptotic events occurring in neutrophils at the site of injury in 
isopimpinellin treated mpx:FRET larvae (Fig. 3E), but no apoptotic events were ever 
seen in the head region of the embryo suggesting this is a inflammation specific 
response. In apoptotic cells we observed loss of the FRET signal, indicative of 
caspase-3 activity, shortly after ‘cell rounding,’ and the YFP acceptor fluorescence 
was lost 5 to 10 minutes later (Fig. 3F). The pro-apoptotic effect of isopimpinellin was 
validated using dual TSA/TUNEL staining, which also revealed an increase in the 
percentage of neutrophil apoptosis at the wound (Fig. 3G). We have previously 
shown that the pan-caspase inhibitor Z-VAD-FMK blocks neutrophil apoptosis, 
whereas pyocyanin and roscovitine can accelerate it (Loynes et al., 2010). To further 
illustrate the utility of this novel transgenic line, we used Z-VAD-FMK to demonstrate 
a reduction in the isopimpinellin induced increase in observable apoptotic events 
(Fig. 3H) and pyocyanin and roscovitine to demonstrate an increase in apoptotic 
events (Fig. 3I), which were revealed in real-time in vivo for the first time. 
 
Isopimpinellin and related disodium cromoglycate do not act as antioxidants 
Isopimpinellin is structurally related to khellin, a naturally occurring benzopyrone also 
found in plants of the Apiaceae family. Originally used in ancient Egyptian folk 
medicine, it was discovered in the mid 1900s that khellin in its isolated form was an 
effective treatment for bronchial asthma, and this led to the development of a series 
of functional benzopyrone analogues including disodium cromoglycate and 
nedocromil (Fig. 4A), collectively termed the ‘cromones’, which are now in clinical 
use (Edwards and Howell, 2000). These and other structurally related coumarins and 
flavonoids have been reported to possess antioxidant activity (Bubols et al., 2013). 
To explore this as a potential mechanism of action for our compounds, we analysed 
their reducing ability using the Ferric Reducing Ability of Plasma (FRAP) assay 
(Benzie and Strain, 1996). Antioxidants are preferentially oxidised over another 
substrate, and their oxidation results in the reduction of another component. 
Therefore, a good antioxidant will also be a good reducing agent. Using this method, 
we found that the known antioxidant ascorbic acid showed strong reducing ability, at 
levels consistent with previous studies (Benzie and Strain, 1996), whilst vanillic acid 
also exhibited substantial reducing ability. However, neither isopimpinellin nor 
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disodium cromoglycate appeared to show appreciable reducing ability in this assay, 
suggesting that these compounds are unlikely to be acting as antioxidants in our 
studies (Fig. 4B, C and Table S1). Furthermore, when we compared the relative 
chemical reducing ability of these 4 compounds with their effect on the resolution of 
inflammation in vivo, we found that there was actually an inverse correlation between 
biological activity and chemical reducing ability (Fig. 4D). Our most active pro-
resolution compounds in vivo showed little chemical reducing ability, whereas neither 
of the known antioxidants ascorbic acid and vanillic acid exhibited a pro-resolution 
effect in our model (Fig. S3). To explore this in an in vivo setting, we measured the 
effect of isopimpinellin on hydrogen peroxide, an important reactive oxygen species 
(ROS) signal known to promote neutrophil accumulation following tissue injury 
(Niethammer et al., 2009). Using a ROS sensor (Rieger and Sagasti, 2011), there 
was no reduction in the intensity of the H2O2 gradient at the tail fin wound in 
zebrafish larvae pretreated with isopimpinellin, in contrast to the potent effect 
observed in the presence of the NAPDH oxidase inhibitor, diphenyleneiodonium 
(DPI) (Fig. 4E, F). Taken together, these data suggest that this subset of compounds 
do not exhibit their activity by acting as antioxidants in our zebrafish inflammation 
assays. 
 
Isopimpinellin and related cromones do not induce human neutrophil apoptosis in 
vitro 
The precise anti-inflammatory mechanisms of the cromones are not fully defined but 
are likely to be mediated by secretion of the calcium and phospholipid binding 
protein, Annexin A1 (AnxA1) (Yazid et al., 2009; Yazid et al., 2010). AnxA1 is 
thought to induce neutrophil apoptosis in a caspase-3 dependent manner and may 
also function as an ‘eat me’ signal to promote the phagocytosis of apoptotic 
neutrophils by macrophages (Arur et al., 2003; Scannell et al., 2007; Vago et al., 
2012). Having observed a pro-apoptotic effect on zebrafish neutrophils in vivo, we 
hypothesised that isopimpinellin and the related clinical cromones might act similarly 
on human neutrophils, and that this might be a previously unidentified pro-resolution 
mechanism of this series of compounds. Neutrophils were freshly isolated from 
whole blood and incubated with isopimpinelln, disodium cromoglycate or nedocromil 
in either the presence or absence of the neutrophil survival signal granuloctye-
macrophage colony-stimulating factor (GM-CSF). Unexpectedly, after 8 hours, we 
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found no difference in the percentage of apoptosis in neutrophils exposed to any of 
the 3 compounds compared to their vehicle control and none of them were able to 
override the survival effect of GM-CSF (Fig. 5A-C). It is known that neutrophil 
lifespan is prolonged by glucocorticoids (Heasman et al., 2003; Liles et al., 1995) 
and it has been suggested that AnxA1 acts as a downstream modulator of their 
effects during the resolution phase of inflammation, by enhancing neutrophil 
apoptosis and efferocytosis (Vago et al., 2012; Dalli et al., 2013). We therefore 
examined the effects of isopimpinellin, disodium cromogylcate and nedocromil on 
neutrophil apoptosis in the presence of dexamethasone. However, we did not detect 
increased apoptosis in neutrophils exposed to dexamethasone in combination with 
any of our compounds (Fig. 5D-F). Although these experiments were not powered to 
detect a small effect, we have excluded a difference of comparable magnitude to the 
in vivo data. 
 
Cromones in clinical use may act indirectly to induce neutrophil apoptosis in vivo 
Our data suggest that isopimpinellin and the related clinical cromones do not have a 
direct effect on neutrophil survival. We suspected that this might be explained by the 
lack of a required stimulus in our in vitro culture system, as we had already observed 
an increase in neutrophil apoptosis during inflammation resolution in zebrafish larvae 
exposed to isopimpinellin. To similarly investigate the effects of disodium 
cromoglycate and nedocromil in vivo, we performed inflammation resolution assays 
and TSA/TUNEL staining in mpx:GFP larvae. Since these cromones are inactive 
when given by immersion (data not shown) (Yazid et al., 2010), we administered 
them at 6 hpi by vascular injection into the Duct of Cuvier, a technique that has been 
used previously for bacterial infection (Benard et al., 2012). At 12 hpi, neutrophil 
numbers at the wound were reduced following injection with either nedocromil or 
disodium cromoglycate in comparison to the vehicle control (Fig. 6A). We also found 
a significant increase in the percentage of apoptosis of neutrophils at the wound in 
nedocromil injected larvae (Fig. 6B-D). The lack of effect in isolated human 
neutrophils in vitro might be explained by an indirect effect of the compound acting 
on neutrophils via another cell type, such as macrophages. To test this, we used a 
combined genetic/pharmacological macrophage ablation system using transgenically 
expressed bacterial nitroreductase combined with metronidazole treatment (Prajsnar 
et al., 2012). When macrophages are partially ablated in this way, there was a less 
D
is
ea
se
 M
o
de
ls
 &
 M
ec
ha
ni
sm
s 
• 
D
M
M
 •
 A
dv
an
ce
 a
rt
ic
le
D
is
ea
se
 M
o
de
ls
 &
 M
ec
ha
ni
sm
s 
• 
D
M
M
 •
 A
dv
an
ce
 a
rt
ic
le
significant effect of isopimpinellin, suggesting a partial dependence on macrophages 
for the isopimpinellin response (Fig. 6E). Taken together, these data suggest that 
isopimpinellin and the clinically available cromones share both structural and 
functional similarity, acting to accelerate inflammation resolution in vivo by indirect 
induction of neutrophil apoptosis. 
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Discussion 
 
Neutrophil-dominated inflammatory diseases remain a significant, worldwide problem 
and there is a major unmet need for more effective treatments. Drug discovery 
strategies focus on targeting the mechanisms that regulate neutrophil recruitment 
and clearance during inflammation resolution, and recent efforts to identify new anti-
inflammatory therapeutics have made use of the zebrafish model (d’Alençon et al., 
2010; Robertson et al., 2014). Many features of the innate immune system are highly 
conserved between zebrafish and mammalian species (Trede et al., 2004). In our tail 
fin injury assay, the cellular components and kinetics of the acute inflammatory 
response are comparable to those in mammalian systems, making this a useful 
model to study inflammation and dissect the mechanisms that may become 
disrupted to cause inflammatory disease (Renshaw et al., 2006).  
 
In this study, we investigated the mechanism of action of a group of structurally 
similar compounds that we identified in our recent in vivo screen for accelerators of 
inflammation resolution (Robertson et al., 2014). We describe the anti-inflammatory 
and pro-resolution activity of isopimpinellin, which, in our assays, was the most 
active compound within this subset. Based on our previous hierarchical cluster 
analysis, we were able to accurately predict that the mechanism by which 
isopimpinellin inhibits neutrophil recruitment is dependent on PI3K signalling. This 
explains, at least in part, the differences in chemotactic behaviour that we observed 
during the recruitment phase of the inflammatory response. Over the course of our 
time-lapses, neutrophils from isopimpinellin treated larvae did not migrate 
preferentially towards the wound and did not travel as quickly or as far as neutrophils 
from control larvae. Directed neutrophil migration relies on polarisation of the cell, 
which is dependent on localised PI3K signalling at the leading edge. Using the 
transgenic lyz/PHAkt reporter line, we showed that isopimpinellin treatment resulted 
in a loss of the plasma membrane localisation of PHAkt-EGFP and a rounded tail 
neutrophil phenotype, similar to the effect of the known PI3K inhibitor LY294002, 
which we and others have previously observed (Yoo et al., 2010; Xang et al., 2013; 
Burgon et al., 2014). Interestingly, LY294002 is structurally similar to the compounds 
we have investigated in this study, and was originally developed as an analogue of 
quercetin, a benzopyrone that inhibits PI3K by blocking the ATP-binding site (Vlahos 
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et al., 1994). We measured a reduction in the polarity index of neutrophils from both 
isopimpinellin treated larvae and those treated with another compound from our 
structurally similar subset, xanthone. Our data suggest that these compounds act 
either directly on or upstream of PI3K, resulting in reduced phosphorylation and 
translocation of the PH domain of Akt to the plasma membrane, and disruption of 
directional migration towards the wound. 
 
Alongside its inhibitory effect on neutrophil recruitment, we found that isopimpinellin 
also accelerated inflammation resolution in vivo. Our data suggest that this occurs as 
a result of increased neutrophil apoptosis, rather than reverse migration, which is 
perhaps to be expected given that PI3K is also thought to be important for neutrophil 
migration away from a wound (Yoo et al., 2010). Neutrophil apoptosis followed by 
phagocytic uptake by macrophages is the best-described process by which 
neutrophils are removed during inflammation resolution (Savill et al., 1989). Current 
approaches to reliably detect neutrophil apoptosis as it occurs in vivo are limited. 
Although it is possible to label apoptotic neutrophils in zebrafish larvae post-fixation, 
this provides only a snapshot of the entire resolution phase. Here, we have 
developed a new in vivo FRET reporter line for caspase-3 activity that enables us to 
visualise neutrophil apoptosis in real-time. When caspase-3 is activated in 
neutrophils, the FRET signal is lost, prior to and independently of the loss of GFP we 
have seen previously when neutrophils undergo apoptosis in our mpx:GFP zebrafish 
(Loynes et al., 2010). Our data indicate that the pro-apoptotic effect of isopimpinellin 
is caspase-3 dependent and although neutrophil apoptosis occurs rarely in zebrafish 
larvae during the inflammatory response, it is possible to pharmacologically 
manipulate this process to promote resolution. Our new reporter line may provide a 
useful tool for studying the mechanisms regulating neutrophil apoptosis in vivo and 
for the identification of compounds that induce neutrophil apoptosis.  
 
Intriguingly, the clinically available mast cell stabilisers, disodium cromoglycate and 
nedocromil, are benzopyrone derivatives with incompletely defined anti-inflammatory 
activity. Given their structural similarity to isopimpinellin, we hypothesised that 
neutrophil apoptosis might be a previously unidentified mechanism of action for 
these compounds. In our human neutrophil assays, we did not detect any change in 
the rate of apoptosis in the presence of isopimpinellin or either of the clinical 
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cromones. This was unexpected, given that similar compounds have been reported 
to induce neutrophil apoptosis in vitro and to override survival factors including GM-
CSF and dexamethasone (Lucas et al., 2012). It is possible that subtle differences in 
the chemical structures of the benzopyrone derivatives may have profound effects 
on their biological activity, for example by affecting target binding, metabolism, or 
their ability to permeate the cell membrane. As we were unable to detect an increase 
in neutrophil apoptosis with nedocromil or disodium cromoglycate in vitro, we cannot 
speculate on the involvement of AnxA1, the release of which can be induced by 
these compounds (Yazid et al., 2010). Given our evidence that nedocromil and 
isopimpinellin can induce neutrophil apoptosis and promote inflammation resolution 
in vivo, we suspect that another stimulus or cell type may be important for mediating 
their activity. Our macrophage ablation experiments suggest that the effect of 
isopimpinellin may be at least partially dependent on macrophages. Further 
investigation is required to dissect this mechanism and establish the effect of 
nedocromil in the absence of these cells. Disodium cromoglycate also accelerated 
inflammation resolution in our system, although we were unable to confirm that this 
was due to an increase in neutrophil apoptosis. Nedocromil was developed as a 
more potent and stable alternative to disodium cromoglycate (Edwards and Stevens, 
1993), which we suspect may explain the difference in activity we observed between 
these two compounds. 
 
The mechanism of action of isopimpinellin and related chromones and coumarins 
remains to be determined. Our FRAP studies indicate that the active compounds we 
tested do not act as antioxidants through single electron transfer. Whilst these 
results alone do not rule out the possibility that they may act as oxygen radical 
scavengers, when taken together with our in vivo data, an antioxidant mechanism 
seems unlikely. We did not observe a reduction in the hydrogen peroxide gradient at 
the site of injury in isopimpinellin treated larvae, in comparison to those treated with 
the NADPH oxidase inhibitor, DPI. However, the ROS sensor used in these 
experiments is not specific to H2O2 and we cannot rule out the possibility that 
isopimpinellin may reduce the levels of other reactive oxygen species. A recent 
report describes antagonism of the AnxA1 receptor, formyl peptide receptor 1 
(FPR1), by a series of benzopyrone analogues (Schepetkin et al., 2014). The precise 
functions of AnxA1 and FPR1 signalling during inflammation resolution have not yet 
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been well established and we suspect that the effects of FPR1 activation over the 
course of the inflammatory response may be temporally dependent. An alternative 
mechanism of action for the cromones has also been proposed, as 2 research 
groups have demonstrated that disodium cromoglycate and nedocromil may activate 
the G-protein coupled receptor GPR35 to induce calcium mobilisation, inositol 
phosphate accumulation and beta-arrestin-2 recruitment in transfected cells (Jenkins 
et al., 2010; Yang et al., 2010).  
 
In summary, we have identified a series of lead compounds with the potential both to 
limit the further recruitment of neutrophils to areas of inflammation and also to 
promote the clearance of persistent neutrophils that are already in situ. This 
combined anti-inflammatory and pro-resolution activity might make these compounds 
particularly valuable for the treatment of chronic inflammatory diseases. Further 
investigation is necessary to determine the precise mechanism of action of 
isopimpinellin and other benzopyrone analogues in vivo. 
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Materials and methods 
 
Reagents 
Isopimpinellin (MicroSource Discovery Systems Inc., Gaylordsville, CT, USA) was 
used at 25 μM unless indicated otherwise. Xanthone was used at 25 μM unless 
stated otherwise, LY294002 at 50 μM, pyocyanin at 50 μM and disodium 
cromoglycate at 0.5 pg/μl (all obtained from Sigma-Aldrich, Poole, UK). Roscovitine 
was used at 20 μM (New England Biolabs, Hitchin, UK) and Z-VAD-FMK at 100 μM 
(Calbiochem, Manchester, UK). Nedocromil was used at 0.4 pg/μl and was a kind gift 
from Professor Rod Flower. The related benzopyrones anthraquinone, 4-
chromanone, 1,2,3,4-tetrahydranaphthalene and xanthene were also obtained from 
SIgma-Aldrich, whereas anthrone and dihydrocoumarin were acquired from Alfa 
Aesar (Heysham, UK) and α-tetralone from L. Light & Co Ltd (Colnbrook, UK). GM-
CSF (from PeproTech, London, UK) was used at 0.01 μg/ml. Zebrafish were treated 
with compounds by immersion, with the exceptions of disodium cromoglycate and 
nedocromil, which were administered by vascular injection into the Duct of Cuvier, 
alongside fluorescein as a marker for successful injection. DMSO (Sigma-Aldrich) or 
water were used as vehicle controls, as indicated. 
 
Analogue compound synthesis 
Compounds were synthesised according to literature procedures as follows: 
MMM101 using a slightly modified procedure (Pirkle and Finn, 1983); MMM103 
(Niwa et al., 2009); MMM115 (Fougerousse et al., 2000; Hirao et al., 1984); 
MMM116P using an adapted method (Mouysset et al., 1988); MMM117 using a 
modified procedure (Bird et al., 1983). 
Transgenic zebrafish generation and maintenance 
Zebrafish were raised and maintained according to standard protocols (Nüsslein-
Volhard and Dahm, 2002), in UK Home Office approved aquaria at the Bateson 
Centre, University of Sheffield. The neutrophil-specific zebrafish line 
Tg(mpx:GFP)i114 (Renshaw et al., 2006), referred to as mpx:GFP, was used for all 
experiments unless stated otherwise. All procedures were performed on larvae at 3 
days post fertilisation (dpf). Inflammation was initiated by tail fin transection and 
neutrophil numbers at the wound were recorded following our standard protocols 
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(Renshaw et al., 2006; Robertson et al., 2014). The Tg(mpx:FRET)sh237 line, 
referred to as mpx:FRET, was generated by BAC recombineering as previously 
described (Renshaw et al., 2006), using a caspase-3 specific FRET reporter (Tyas et 
al., 2000). 
 
In vivo neutrophil recruitment assays 
For neutrophil recruitment assays, mpx:GFP larvae were treated with compounds at 
the dose indicated immediately after wounding and numbers of neutrophils at the site 
of injury were counted at 6 hours post injury (hpi). To track neutrophil migration 
during the recruitment phase of inflammation, larvae were pretreated for 2 hours 
prior to tail fin transection, followed by mounting in 0.8% low-melting point agarose 
containing the appropriate drug at 1 hpi. A 2 hour time-lapse series was captured 
and neutrophils were manually tracked using Volocity™ imaging software 
(PerkinElmer Life and Analytical Sciences, Cambridge, UK) for analysis of speed, 
meandering index, displacement and bearing, as previously described (Elks et al., 
2011; Robertson et al., 2014). PI3K assays were performed using 
Tg(lyz.PHAkt:GFP)i277 larvae, which were pre-incubated with test compounds for 2 
hours, followed by wounding, imaging and polarity analysis as described (Wang et 
al., 2013).  
 
In vivo inflammation resolution assays 
For inflammation resolution assays, mpx:GFP larvae were treated at 6 hpi once 
inflammation was already established, and neutrophil numbers at the wound were 
counted at 12 hpi. Total neutrophil numbers were analysed in uninjured larvae 
following compound treatment for 24 hours, as previously described (Robertson et 
al., 2014). Images were converted to 8-bit, binary TIFs using ImageJ (NIH), and the 
‘Measure’ function was used to count the number of neutrophils in an automated 
manner. Reverse migration assays were performed using 
Tg(mpx:Gal4);Tg(UAS:Kaede)i222 larvae following established methods (Elks et al., 
2011, Holmes et al., 2012). Neutrophil apoptosis was measured in 
paraformaldehyde-fixed larvae following Tyramide Signal Amplification staining 
(TSATM-Plus, PerkinElmer) to label neutrophil myeloperoxidase and using an 
ApopTag® Red In Situ Apoptosis Detection Kit (TUNEL) (Millipore Corporation, 
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Herts, UK) to label apoptotic cells, as previously described (Elks et al., 2011). The 
percentage of neutrophil apoptosis was measured using Volocity™ software.  
 
FRET assay 
Tail fin transection was performed on Tg(mpx:FRET)sh237 larvae at 3 dpf followed 
by treatment with compounds at 4 hpi. Larvae were mounted and FRET imaging was 
performed from 6 hpi. Embryos were imaged for 6 hours on a TE-2000U microscope 
(Nikon, Japan) with an Orca-AG Camera (Hamamatsu, Japan) using Volocity™ 
imaging software. Donor fluorescence was imaged with a D436/20x CFP excitation 
filter and a D480/40m CFP emission filter. Acceptor fluorescence was imaged with a 
HQ500/20x YFP excitation filter and a HQ535/30m emission filter. FRET images 
were taken with the CFP excitation and the YFP emission filters, using a 455DCLP 
dichroic mirror (Chroma, Germany). Spectral bleed-through constants were 
calculated using fixed HEK293T cells transfected with either p1CFP or p1YFP and 
mounted in VECTASHIELD mounting media (Vector Laboratories, Peterborough, 
UK). Volocity™ was used to calculate NFRET (Xia and Liu, 2001). 
 
In vivo antioxidation assays 
At 3 dpf, zebrafish larvae (nacre) were treated with DMSO, isopimpinellin or DPI 
(100 μM, Sigma-Aldrich) for 2 hours prior to injury. Incubation in the appropriate 
compound was continued during injury and subsequent imaging. During the 
pretreatment period, the larvae were also incubated in pentafluorobenzenesulfonyl 
fluorescein (10 μM, Santa Cruz Biotechnology, Santa Cruz, CA, USA), in the dark for 
1 hour. The dye was removed prior to mounting. After 2 hour pretreatment, larvae 
were mounted in agarose containing the appropriate compound. A window was cut 
in the agarose to allow prompt imaging of the larval tail after injury. Tail fin 
transection was performed and imaging commenced at 5 minutes post injury (mpi). 
Mean fluorescent intensity at the injury site was measured at 5 mpi and 20 mpi using 
ImageJ. Mean fluorescent intensity at 20 mpi was expressed as a percentage of the 
mean fluorescent intensity at 5 mpi. 
 
Ferric Reducing Ability of Plasma (FRAP) assays 
The method of Benzie and Strain (1996) was followed with slight modifications. 300 
mM acetate buffer (pH 3.6) was prepared from 3.1 g sodium acetate trihydrate (Alfa 
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Aesar, Heysham, UK) and 16 mL glacial acetic acid (VWR International, Lutterworth, 
UK) made up to 1 L with distilled water. Other reagents used were 10 mM TPTZ 
(Sigma-Aldrich) in 40 mM hydrochloric acid (VWR International), and aqueous 20 
mM iron (III) chloride hexahydrate (BDH Laboratory Supplies, Poole, UK). FRAP 
reagent was prepared freshly as required, by mixing 10 mL acetate buffer, 1 mL 
TPTZ solution and 1 mL iron (III) chloride hexahydrate solution. Aqueous standard 
solutions of iron (II) at concentrations of 100, 200, 400, 600, 800 and 1000 µM were 
prepared using iron (II) sulfate heptahydrate (Sigma-Aldrich), and their absorbances 
at 593 nm at 37°C were used for calibration of the assay, using a line of best fit as 
determined by linear regression analysis. Solid L-(+)-ascorbic acid, vanillic acid and 
disodium cromoglycate (all obtained from Sigma-Aldrich) were tested as aqueous 
solutions, whilst isopimpinellin was used as an ethanolic solution. All compounds 
were tested at both 100 µM and 400 µM. All UV-Visible spectrometry was carried out 
using a Cary 50 Probe UV-Visible Spectrophotometer (Varian) pre-warmed to 37°C 
using a water bath, and in a quartz cuvette of 1 cm path length. Absorbance values 
at 593 nm were plotted using the Cary WinUV Kinetics application (Varian, version 
3.00). 3 mL freshly prepared FRAP reagent in a quartz cuvette was warmed to 37 
°C, and a blank reading was taken at 593 nm. A 100 µL sample of compound 
solution was then added, and absorbance readings were taken after 0.1 s and then 
at 15 s intervals for a total of 5 minutes (after which the absorbance values for most 
samples had stabilised). These were then corrected relative to the blank reading. 
The absorbance value of the sample at 5 minutes was then used for all future 
calculations. For each sample, the effective iron (II) concentration in solution 
corresponding to that absorbance value was determined, using the calibration graph 
(described above). This value was then compared to the corresponding iron (II) 
standard value for the same concentration of reagent (i.e. 100 or 400 µM), and was 
expressed as a ratio, for each of the 2 concentrations tested. These ratios were then 
used to determine the mean ratio for each compound, referred to as the chemical 
reducing ability value. 
Macrophage ablation experiments 
Zebrafish larvae from Tg(mpeg:gal4)SH256; Tg(UAS:nfsB.mCherry)C264; 
Tg(mpx:GFP)i114 zebrafish were raised to 2 dpf and then incubated with or without 
metronidazole (5 mM) for approximately 16 hours. At 3 dpf, tail fin transection was 
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performed and larvae were returned to metronidazole (1.25 mM) or vehicle only for 
the remainder of the experiment. At 6 hpi, larvae with a good inflammatory response 
were treated with isopimpinellin or DMSO. At 12 hpi, the number of neutrophils at the 
site of injury was counted. All groups were kept in the dark throughout the 
experiment. 
 
Human neutrophil apoptosis assay 
Peripheral blood neutrophils were purified using the Percoll method of separation, as 
described previously (Haslett et al., 1985), in accordance with the South Sheffield 
Research Ethics Committee (reference number: STH13927). Rates of neutrophil 
apoptosis based on morphology were counted on cytospins stained with Quick-Diff 
(Gentaur, Brussels, Belgium). 
 
Statistical analysis 
Data were analysed (Prism 6.0; GraphPad Software, CA, USA) using unpaired, two-
tailed t-tests for comparisons between two groups and one-way ANOVA (with 
appropriate post-test adjustment) for other data. In all cases, mean +/- SEM are 
shown and procedures were performed and analysed blind to experimental 
conditions.  
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Figures 
 
 
 
 
Fig 1. Isopimpinellin inhibits neutrophil migration towards tissue injury. 
(A) Isopimpinellin shares structural similarity to 3 other compounds identified in our 
previous drug screen for accelerators of inflammation resolution (Robertson et al., 
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2014). Common benzopyrone structures are highlighted in magenta. (B) Recruitment 
assay in mpx:GFP larvae, treated with varying doses of isopimpinellin immediately 
post injury. Isopimpinellin significantly reduces neutrophil numbers at the wound at 6 
hpi in a dose-dependent manner (one-way ANOVA with Dunnett’s multiple 
comparison post-test; *P<0.05, ***P<0.001; n=18, performed as 3 independent 
experiments). Dotted line at y=20.17 indicates mean neutrophil number at wound in 
DMSO control larvae. (C-F) Neutrophil tracking assay in mpx:GFP larvae, pretreated 
with DMSO or 25 μM isopimpinellin for 2 hours prior to tail fin injury and time-lapsed 
from 1 to 3 hpi. Individual neutrophils were tracked manually to analyse (C) speed, 
(D) displacement towards the wound and (E) meandering index. All were reduced in 
isopimpinellin treated larvae compared to DMSO controls (unpaired t test; 
***P<0.001; n=26, performed as 3 independent experiments). Data points represent 
mean of 6 tracked neutrophils per fish. For bearing (F), angles of 0° to 180° indicate 
migration towards the wound whereas 180° to 360° indicate migration away from the 
wound (one-way ANOVA with Bonferroni’s multiple comparison post-test to compare 
selected columns; ***P<0.001; n=30, performed as 3 independent experiments).  
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Fig 2. Isopimpinellin and xanthone inhibit polarisation of neutrophils upstream 
of PI3K. 
Assay to measure polarity index of neutrophils in Tg(lyz:PHAkt-EGFP) larvae, 
pretreated with 25 μM isopimpinellin,  25 μM xanthone, 50 μM LY294002 or DMSO 
as a vehicle control for 2 hours prior to tail fin injury. Representative images of 
individual neutrophils in the region between the wound site and posterior blood 
island illustrate polarisation and defined leading edge of a migrating neutrophil in (A) 
DMSO control treated larvae, compared to (B) isopimpinellin and (C) LY294002 
treated larvae, which do not polarise or have a defined leading edge (scale bar 
represents 11 μm).  Arrows indicate direction of wound. Fluorescence (referred to as 
grey value) was measured in a transection of each neutrophil (the yellow lines drawn 
through the cells) to generate intensity profiles shown in the panels on the right and 
quantify neutrophil polarity index as previously described (Wang et al., 2013). Both 
(D) isopimpinellin and (E) xanthone reduced neutrophil polarity index to a similar 
level as the known PI3K inhibitor LY294002 (one-way ANOVA with Dunnett’s 
multiple comparison post-test; ***P<0.001; n=27, performed as 3 independent 
experiments). 
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Fig 3. Isopimpinellin accelerates inflammation resolution in vivo by inducing 
neutrophil apoptosis. 
(A) Inflammation resolution assay in mpx:GFP larvae, treated with varying doses of 
isopimpinellin at 6 hpi. Isopimpinellin significantly reduces neutrophil numbers at the 
wound at 12 hpi in a dose-dependent manner (one-way ANOVA with Dunnett’s 
multiple comparison post-test; **P<0.01, ***P<0.001; n=18, performed as 3 
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independent experiments). Dotted line at y=18.5 indicates mean neutrophil number 
at wound in DMSO control larvae. (B) Total neutrophil number measured in 
mpx:GFP larvae, treated with DMSO or 25 μM isopimpinellin for 24 hours. 
Isopimpinellin did not affect total neutrophil number (unpaired t test; P=0.8696; n=18, 
performed as 3 independent experiments). (C) Reverse migration assay in 
mpx/Kaede larvae, treated with DMSO or 25 μM isopimpinellin from 4 hpi. 
Neutrophils at the site of injury were photoconverted at 6 hpi and the numbers of 
photoconverted cells that moved away from the wound were quantified over 5 hours. 
Neutrophils migrated away from the wound at a slower rate in isopimpinellin treated 
larvae compared to DMSO control larvae. (D) Representative image of isopimpinellin 
treated mpx/Kaede larvae at 8 hpi (scale bar represents 70 μm). White arrows in 
magnified view indicate neutrophils that appear apoptotic. (E, F) FRET assay in 
Tg(mpx:FRET)sh237 larvae, treated with DMSO or 25 μM isopimpinellin from 4 hpi 
and imaged from 6 hpi. Cleavage of the caspase-3 target site results in separation of 
the fluorophores and loss of the FRET signal (red). Acceptor (neutrophil) 
fluorescence (green) persists for a further 10 to 20 minutes before cell death and 
loss of fluorophore integrity. Time is shown as hours:minutes. Scale bar represents 
50 μm. Number of observable apoptotic events was increased in isopimpinellin 
larvae (unpaired t test; ***P<0.001; n=18, performed as 3 independent experiments). 
(G) TUNEL assay in mpx:GFP larvae, treated with DMSO or 25 μM isopimpinellin 
from 6 hpi and fixed at 12 hpi. Numbers of TSA-positive neutrophils and TSA/TUNEL 
double positive apoptotic neutrophils at the site of injury were measured to calculate 
percentage neutrophil apoptosis, which was increased in isopimpinellin treated 
larvae (unpaired t test; ***P<0.001; n=115, performed as 2 independent 
experiments). (H) Larvae were treated with DMSO, 100 μM Z-VAD-FMK (zVAD), 25 
μM isopimpinellin (Iso) or in combination (Iso + zVAD) from 4 hpi and imaged from 6 
hpi. Number of observable apoptotic events was increased with isopimpinellin alone 
but the effect was lost with the addition of Z-VAD-FMK (one-way ANOVA with 
Bonferroni’s multiple comparison post-test to compare selected columns; *P<0.05; 
n=14, performed as 3 independent experiments). (I) Larvae were treated with 
DMSO, 20 μM roscovitine or 50 μM pyocyanin from 4 hpi and imaged from 6 hpi. 
Number of observable apoptotic events was increased with pyocyanin (one-way 
ANOVA with Bonferroni’s multiple comparison post-test to compare selected 
columns; *P<0.05; n=18, performed as 3 independent experiments).   
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Fig 4. Isopimpinellin and disodium cromoglycate do not have antioxidant 
activity. 
(A) Isopimpinellin is a structural isomer of khellin, from which a series of functional 
benzopyrone analogues were designed, including disodium cromoglycate and 
nedocromil. (B,C) FRAP assay, performed at 37°C for 5 minutes. Graphs show rate 
of increase in absorbance at 593 nm, corrected for reagent blank readings, at (B) 
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100μM and (C) 400 μM of each compound, as indicated. (D) The in vivo activity of 
the compounds tested (expressed as the percentage decrease in the mean 
neutrophil numbers at the wound at 12 hpi, in comparison to the vehicle control 
(refers to data from Figs 3A, 6A and S3), plotted against the chemical reducing 
ability value (refers to data from Table 1) (linear regression analysis; R2=0.8960; 
P=0.535). (E) In vivo antioxidation assay. Larvae were pretreated with DMSO, 
isopimpinellin or DPI for 2 hours and pentafluorobenzenesulfonyl fluorescein for 1 
hour prior to tail fin injury. Imaging commenced 5 minutes post injury (mpi) and mean 
fluorescence intensity at the injury site was measured at 5 and 20 mpi. Mean 
fluorescent intensity at 20 mpi is expressed as a percentage of the mean fluorescent 
intensity at 5 mpi. This was significantly reduced by DPI but isopimpinellin had no 
effect (one-way ANOVA with Dunnett’s multiple comparison post-test; ****P<0.0001; 
n>15, performed as 2 independent experiments). Illustrative images are shown in 
(F). 
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Fig 5. Isopimpinellin and related clinical cromones have no effect on human 
neutrophil apoptosis in vitro. 
(A-F) Human neutrophils were isolated from whole blood and incubated for 8 hours 
with (+) or without (-) 0.01 μg/ml GM-CSF or 1 μM dexamethasone as indicated, and 
10 μM (A, D) isopimpinellin, (B, E) disodium cromoglycate or (C, F) nedocromil. In 
each case, 2 cytospins (technical replicates) were acquired per condition and the 
percentage of neutrophil apoptosis was calculated based on nuclear morphology. 
Experiments in A, B and D-F were performed at the same time using the same 
controls. Isopimpinellin, disodium cromoglycate and nedocromil did not induce 
neutrophil apoptosis compared to their vehicle controls, or inhibit neutrophil survival 
induced by either GM-CSF or dexamethasone (one-way ANOVA with Bonferroni’s 
multiple comparison post-test to compare selected columns; P>0.05 for all 
comparisons; n=2, performed as independent experiments from 2 different donors 
performed on different days). 
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Fig 6. Clinical cromones promote neutrophil apoptosis to drive inflammation 
resolution in vivo. 
(A) Inflammation resolution assay in mpx:GFP larvae, injected with 0.4 pg/μl of 
nedocromil or 0.5 pg/μl disodium cromoglycate at 6 hpi. Both compounds 
significantly reduce neutrophil numbers at the wound at 12 hpi compared to the 
water control (one-way ANOVA with Dunnett’s multiple comparison post-test; 
**P<0.01, ***P<0.001; n>36, performed as 4 independent experiments). (B-D) 
TUNEL assay in mpx:GFP larvae, injected with water or 0.4 pg/μl of nedocromil or 
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0.5 pg/μl disodium cromoglycate from 6 hpi and fixed at 12 hpi. Numbers of TSA-
positive neutrophils and TSA/TUNEL double positive apoptotic neutrophils at the site 
of injury were measured to calculate percentage neutrophil apoptosis, which was 
increased in nedocromil treated larvae (one-way ANOVA with Dunnett’s multiple 
comparison post-test; *P<0.05; n>54, performed as 3 independent experiments). (C, 
D) Illustrative images of water injected (D) and nedocromil injected (E) larvae 
following TSA/TUNEL staining (scale bar represents 40 μm). White arrows in 
magnified view of (D (iv)) indicate apoptotic neutrophils, identified by morphology 
and double TSA/TUNEL labelling. (E) Inflammation resolution assay in the absence 
of macrophages. Metronidazole ablation of macrophages impairs the effect of 
isopimpinellin (one-way ANOVA with Bonferroni’s multiple comparison post-test to 
compare selected columns; *P<0.05; n>20; performed as 3 independent 
experiments). 
D
is
ea
se
 M
o
de
ls
 &
 M
ec
ha
ni
sm
s 
• 
D
M
M
 •
 A
dv
an
ce
 a
rt
ic
le
